SMTL ID : 6uyd.2 (1 other biounit)

Structure of Hepatitis C Virus Envelope Glycoprotein E2mc3-v1 redesigned core from genotype 1a bound to broadly neutralizing antibody AR3C

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 5 residues within 4Å: Chain C: N.111, S.112, T.113, F.115, K.117 1 PLIP interactions: 1 interactions with chain C Hydrophobic interactions: C:F.115

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.2: 3 residues within 4Å: Chain C: H.10, N.12, Y.86 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

He, L. et al., Proof of concept for rational design of hepatitis C virus E2 core nanoparticle vaccines. Sci Adv (2020)

Release Date

2020-04-22

Peptides

Fab AR3C heavy chain: A
Fab AR3C light chain: B
Envelope glycoprotein E2: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
F

Fab AR3C heavy chain

Fab AR3C light chain

Envelope glycoprotein E2

Related Entries With Identical Sequence